Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2026-02-27 @ 10:38 AM
Study NCT ID:
NCT00865969
Status:
COMPLETED
Last Update Posted:
2021-10-29
First Post:
2009-03-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PXD101-CLN-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |